Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests if teaching parents early feeding can stop food allergies

NCT ID NCT07321522

Prevention Sponsor: Stanford University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving parents educational materials and in-person feeding support helps them introduce allergenic foods like eggs to infants early and keep them in the diet. Researchers will compare two groups of 92 infants to see which approach leads to earlier and more sustained feeding. The goal is to find practical ways to prevent food allergies from developing.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
educational modules and clinician-supervised feeding
What this could lead to
If successful, this could show that simple education and support help parents safely introduce allergenic foods early, potentially reducing food allergy rates.
What could go wrong
This is a small pilot study, so results may not apply broadly. The intervention is behavioral, not a drug, so any effect on allergy prevention is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 92 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 11 months

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for both Infant and Caregiver/Parent Participants * Born term (37 weeks - 41 weeks gestation) * Infants with or without a family history of allergic disease * Infants with or without mild to moderate eczema * Infants who have not yet started consuming known allergenic foods (excluding cow's milk or soy if it is in their infant formula) * Parent or caregiver ≥ 18 years of age * Agree to infant blood draw (two) * Agree to participate in the 6 month research study Exclusion Criteria: * Infants with a physician confirmed food allergy * Infants who do not eat fully by an oral route such as tube-fed or tube-supplemented babies * Infants with developmental delay * Infants with severe eczema * Infants who are already consuming known allergenic foods * Infants participating in another study looking at diet, oral immunotherapy or the use of a biological agent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Food allergy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

food allergy prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Food allergy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Stanford University

    RECRUITING

    Stanford, California, 94305, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.